Stock listing
Taimed Biologics Inc.
Selected listing: 4147 · TPEX · TWD · TW
Taimed Biologics Inc. (TPEx:4147), Health Technology. Latest release Jul 7, 2026: TaiMed Biologics (4147) Receives TFDA Drug License Collection Notice…
- Ticker
- TPEx:4147
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- TPEx
- Currency
- TWD
About Taimed Biologics Inc.
Taimed Biologics Inc. is a public company listed on the Taiwan stock market under the ticker 4147. Taimed Biologics focuses on the development of innovative biologic therapies.
Latest news from Taimed Biologics Inc.
TaiMed Biologics (4147) Receives TFDA Drug License Collection Notice for Trogarzo, Marking the Final Step Toward Commercial Launch in Taiwan
July 7, 2026
TaiMed Biologics Completes Phase 2b Enrollment for TMB-365/380 in HIV Maintenance Therapy Study
May 20, 2026
TaiMed Biologics : First Patient Enrolled in the Study Evaluating Bi-monthly and Quarterly Dosing of the Long-Acting TMB-365/TMB-380 mAb Combination Maintenance Therapy
July 28, 2022
TaiMed Biologics : Important Resolutions of the Company's 2022 General Shareholders' Meeting
May 30, 2022
TaiMed Biologics : Announcement of members of the Company's Compensation Committee
May 30, 2022
Research Taimed Biologics Inc.
Taimed Biologics Inc. company profile
View the public company page for Taimed Biologics Inc. on 6ix.
Taimed Biologics Inc. news
Read company news and market updates connected to Taimed Biologics Inc..
Taimed Biologics Inc. investor events
Find investor webinars, events, and replay context for Taimed Biologics Inc..